Jacobs Levy Equity Management
SCPH

Jacobs Levy Equity Management’s scPharmaceuticals SCPH Stock Holding History

Jacobs Levy Equity Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-81,891
Closed -$411K – 1076
2021
Q4 		$411K Sell
81,891
-20,316
-20% -$112K ﹤0.01% 859
2021
Q3 		$680K Sell
102,207
-36,397
-26% -$217K ﹤0.01% 822
2021
Q2 		$847K Sell
138,604
-2,363
-2% -$14.3K 0.01% 773
2021
Q1 		$937K Buy
140,967
+114,803
+439% +$787K 0.01% 750
2020
Q4 		$138K Buy
+26,164
New +$205K ﹤0.01% 980
2020
Q1 		– Sell
-17,791
Closed -$101K – 1083
2019
Q4 		$101K Buy
17,791
+3,157
+22% +$16.2K ﹤0.01% 975
2019
Q3 		$86K Sell
14,634
-22,287
-60% -$126K ﹤0.01% 896
2019
Q2 		$118K Buy
36,921
+13,225
+56% +$43.3K ﹤0.01% 910
2019
Q1 		$71K Buy
+23,696
New +$81.4K ﹤0.01% 941

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $750M AUM 52.68% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return